Related Experiment Videos
Famotidine has no significant effect on gonadal function in man
V Savarino1, M Giusti, P Scalabrini
1Istituto Scientifico di Medicina Interna, Università di Genova, Italy.
Gastroenterologie Clinique Et Biologique
|January 1, 1988
Summary
Famotidine, a new H2 blocker, was tested in male patients with duodenal ulcers. The study found no significant effects on testosterone, gonadotrophins, or seminal fluid, indicating famotidine does not impact male gonadal function.
Area of Science:
- Gastroenterology
- Endocrinology
- Pharmacology
Background:
- Duodenal ulcers are common gastrointestinal issues.
- H2 blockers are widely used for acid suppression.
- Famotidine is a newer H2 blocker with a known safety profile.
Purpose of the Study:
- To investigate the potential impact of famotidine on male gonadal function.
- To assess famotidine's effect on hormonal levels and seminal characteristics.
- To determine if famotidine influences reproductive health in men.
Main Methods:
- Eight male patients with duodenal ulcers were enrolled.
- Famotidine 40 mg was administered orally as a single bedtime dose for 4 weeks.
- Serum levels of testosterone, luteinizing hormone (LH), and follicle-stimulating hormone (FSH) were measured.
- Seminal fluid analysis was performed in 5 patients before and after treatment.
Main Results:
- Famotidine did not alter basal or stimulated serum testosterone levels.
- No significant changes were observed in luteinizing hormone (LH) or follicle-stimulating hormone (FSH) levels.
- Seminal fluid characteristics remained unchanged in the evaluated patients.
Conclusions:
- Famotidine, at a dose of 40 mg, does not appear to affect male gonadal function.
- The H2 blocker famotidine shows no adverse effects on reproductive hormones or semen quality.
- Clinical use of famotidine is unlikely to impact male fertility or endocrine health.